Variant report
Variant | nsv998811 |
---|---|
Chromosome Location | chr3:28849038-28875273 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:2)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:2 , 50 per page) page:
1
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs568923470 | chr3:28849480-28849481 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs531351659 | chr3:28849502-28849503 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs551333658 | chr3:28849572-28849573 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs569531250 | chr3:28849606-28849607 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs34988623 | chr3:28849655-28849656 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs145239741 | chr3:28849663-28849664 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs149146418 | chr3:28849668-28849669 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs540487737 | chr3:28849676-28849677 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs567072139 | chr3:28849706-28849707 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs536054681 | chr3:28849708-28849709 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs556127434 | chr3:28849821-28849822 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs6775655 | chr3:28849823-28849824 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
13 | rs537983946 | chr3:28849832-28849833 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs142272564 | chr3:28849861-28849862 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs578081935 | chr3:28849877-28849878 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs540900330 | chr3:28849887-28849888 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs151337379 | chr3:28849924-28849925 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs185584469 | chr3:28849956-28849957 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs191425599 | chr3:28849965-28849966 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs562966708 | chr3:28849968-28849969 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs183253766 | chr3:28849982-28849983 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs554191294 | chr3:28850823-28850824 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs137970916 | chr3:28850941-28850942 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs557716497 | chr3:28850995-28850996 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs372795143 | chr3:28851027-28851028 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs191146761 | chr3:28851045-28851046 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs60769807 | chr3:28851096-28851097 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs9841420 | chr3:28851142-28851143 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
29 | rs34489889 | chr3:28851183-28851184 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs190906521 | chr3:28856003-28856004 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs553595401 | chr3:28856004-28856005 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs573262838 | chr3:28856022-28856023 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs182074736 | chr3:28856034-28856035 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs544348396 | chr3:28856078-28856079 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs1604070 | chr3:28856091-28856092 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
36 | rs187835610 | chr3:28856163-28856164 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs544875360 | chr3:28856171-28856172 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs9830243 | chr3:28856181-28856182 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
39 | rs578260266 | chr3:28856218-28856219 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs74980672 | chr3:28856219-28856220 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs560552543 | chr3:28856232-28856233 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs528967951 | chr3:28856243-28856244 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs548826567 | chr3:28856283-28856284 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs540827069 | chr3:28856284-28856285 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs560452683 | chr3:28856302-28856303 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs192427738 | chr3:28856344-28856345 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs183204791 | chr3:28856403-28856404 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs551002450 | chr3:28856420-28856421 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs571202413 | chr3:28856465-28856466 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs533860911 | chr3:28856473-28856474 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Chronic lymphocytic leukemia | 21546498 | CNVD |
Breast cancer | 17603634 | CNVD |
Neuroblastoma | 17327916 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Colorectal cancer | 21297112 | CNVD |
Lynch syndrome | 18415027 | CNVD |
Renal cell carcinoma | 18592004 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Urothelial carcinoma | 18382360 | CNVD |
Melanoma | 18172304 | CNVD |
Cervical cancer | 21062161 | CNVD |
Hirschsprung''s Disease | 21712996 | CNVD |
head and neck squamous cell carcinoma | 17671120 | CNVD |
Insulin resistance | 16721378 | CNVD |
Neuroblastoma | 18664255 | CNVD |
Monoclonal gammopathy of undetermined significance | 17077331 | CNVD |
Multiple myeloma | 17077331 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Neuroblastoma | 21484798 | CNVD |
Non-small cell lung cancer | 21044232 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Oral cancer | 19627613 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
Epithelial cancer | 22065749 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Liposarcoma | 21253554 | CNVD |
Basal cell lymphoma | 21115979 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Pancreatic endocrine tumor | 20981439 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 21264507 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Oral cancer | 21386901 | CNVD |
Cutaneous squamous cell carcinomas | 19131950 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Uveal melanoma | 21693616 | CNVD |
Retinoblastoma | 21504564 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Renal cell carcinoma | 21668985 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Lung cancer | 20668451 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Lung cancer | 18438408 | CNVD |
Intellectual disability | 22102821 | CNVD |
Esophageal cancer | 20955586 | CNVD |
Myeloproliferative neoplasm | 20015882 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Myofibroblastic sarcoma | 19369631 | CNVD |
Squamous cell cancer | 20885788 | CNVD |
Breast cancer | 17133270 | CNVD |
Uveal melanoma | 20484589 | CNVD |
Autism | 22495311 | CNVD |
Melanoma | 20688739 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Lung cancer | 16618734 | CNVD |
Cancer | 20164919 | CNVD |
Developmental delay | 21147756 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr3:28849400-28850000 | Enhancers | Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells | embryonic stem cell |
2 | chr3:28850800-28851200 | Enhancers | Dnd41 | blood |
3 | chr3:28856000-28856600 | Enhancers | Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells | embryonic stem cell |
4 | chr3:28863600-28877200 | Weak transcription | Aorta | Aorta |
5 | chr3:28865800-28866200 | Enhancers | Breast Myoepithelial Primary Cells | Breast |
6 | chr3:28868200-28868800 | Enhancers | H1 BMP4 Derived Mesendoderm Cultured Cells | ES cell derived |
7 | chr3:28875000-28875200 | Enhancers | HUES64 Cell Line | embryonic stem cell |
8 | chr3:28875200-28875600 | Enhancers | HUES6 Cell Line | embryonic stem cell |
9 | chr3:28875200-28877000 | Weak transcription | HUES64 Cell Line | embryonic stem cell |